Evercore ISI Cuts Healthpeak Properties (NYSE:DOC) Price Target to $21.00

Healthpeak Properties (NYSE:DOC) had its target price cut by Evercore ISI from $23.00 to $21.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an outperform rating on the real estate investment trust’s stock.

A number of other research firms have also recently weighed in on DOC. Scotiabank cut their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research note on Friday, February 28th. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, April 23rd. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Robert W. Baird cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. Finally, Wedbush decreased their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a research report on Monday. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $23.42.

Healthpeak Properties Stock Performance

Shares of DOC opened at $17.86 on Monday. Healthpeak Properties has a 1 year low of $17.33 and a 1 year high of $23.26. The stock has a market capitalization of $12.49 billion, a PE ratio of 51.03, a PEG ratio of 2.17 and a beta of 1.02. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a 50-day simple moving average of $19.46 and a 200-day simple moving average of $20.49.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same quarter in the previous year, the firm earned $0.45 earnings per share. The firm’s quarterly revenue was up 15.9% on a year-over-year basis. On average, analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a dividend, which was paid on Wednesday, April 30th. Stockholders of record on Friday, April 18th were paid a dividend of $0.1017 per share. This represents a dividend yield of 6.5%. The ex-dividend date of this dividend was Thursday, April 17th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 305.00%.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 11,337 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the acquisition, the chief executive officer now directly owns 201,863 shares of the company’s stock, valued at $3,568,937.84. This represents a 5.95 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John T. Thomas purchased 4,200 shares of the firm’s stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the purchase, the director now owns 813,566 shares of the company’s stock, valued at approximately $14,514,017.44. This represents a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.23% of the stock is owned by insiders.

Institutional Trading of Healthpeak Properties

Hedge funds and other institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its holdings in Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Geode Capital Management LLC increased its stake in Healthpeak Properties by 3.6% in the 4th quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust’s stock valued at $371,168,000 after purchasing an additional 638,012 shares in the last quarter. Principal Financial Group Inc. increased its stake in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock valued at $367,575,000 after purchasing an additional 17,314,572 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in Healthpeak Properties by 10.6% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust’s stock worth $350,021,000 after purchasing an additional 1,651,235 shares during the last quarter. Finally, Centersquare Investment Management LLC boosted its position in Healthpeak Properties by 3.7% during the fourth quarter. Centersquare Investment Management LLC now owns 11,215,516 shares of the real estate investment trust’s stock worth $227,339,000 after purchasing an additional 398,770 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.